These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11904520)

  • 1. Evidence that lacidipine at nonsustained antihypertensive doses activates nitrogen monoxide system in the endothelium of salt-loaded Dahl-S rats.
    Crespi F; Vecchiato E; Lazzarini C; Andreoli M; Gaviraghi G
    J Cardiovasc Pharmacol; 2002 Apr; 39(4):471-7. PubMed ID: 11904520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrochemical evidence that lacidipine stimulates release of nitrogen monoxide in rat aorta.
    Crespi F; Vecchiato E; Lazzarini C; Gaviraghi G
    Neurosci Lett; 2001 Feb; 298(3):171-4. PubMed ID: 11165434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular protection of lacidipine in salt-loaded Dahl-S rats at nonsustained antihypertensive doses.
    Cristofori P; Terron A; Micheli D; Bertolini G; Gaviraghi G; Carpi C
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S75-85; discussion S85-6. PubMed ID: 1726012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lacidipine prevents endothelial dysfunction in salt-loaded stroke-prone hypertensive rats.
    Krenek P; Salomone S; Kyselovic J; Wibo M; Morel N; Godfraind T
    Hypertension; 2001 Apr; 37(4):1124-8. PubMed ID: 11304513
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies.
    Micheli D; Collodel A; Semeraro C; Gaviraghi G; Carpi C
    J Cardiovasc Pharmacol; 1990 Apr; 15(4):666-75. PubMed ID: 1691398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lacidipine: experimental evidence of vasculoprotective properties.
    Cristofori P; Micheli D; Terron A; Gaviraghi G
    J Cardiovasc Pharmacol; 1994; 23 Suppl 5():S90-3. PubMed ID: 7609515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lacidipine: prevention of vascular damage induced by hypertension.
    Gaviraghi G; Micheli D; Terron A; Cristofori P
    J Cardiovasc Pharmacol; 1991; 18 Suppl 11():S7-12. PubMed ID: 1725448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoration of endothelial cell function by chronic cicletanine treatment in Dahl salt-sensitive rats with salt-induced hypertension.
    Hirawa N; Uehara Y; Kawabata Y; Akie Y; Ichikawa A; Funahashi N; Goto A; Omata M
    Hypertens Res; 1996 Dec; 19(4):263-70. PubMed ID: 8986457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of lacidipine, a vascular-selective calcium antagonist.
    Micheli D; Ratti E; Toson G; Gaviraghi G
    J Cardiovasc Pharmacol; 1991; 17 Suppl 4():S1-8. PubMed ID: 1725998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of combination of angiotensin receptor blocker and calcium channel blocker on ox-LDL levels and cardiovascular dysfunction in Dahl rats.
    Takayama M; Arakawa E; Yao K; Ina Y; Sato H; Hasegawa K; Kohno H; Ohno T
    Pharmacology; 2006; 77(4):179-87. PubMed ID: 16864986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydropyridines, nitric oxide and vascular protection.
    Crespi F
    Curr Vasc Pharmacol; 2005 Apr; 3(2):195-205. PubMed ID: 15853639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardiac and vascular effects of lacidipine.
    Agabiti-Rosei E
    J Cardiovasc Pharmacol; 1995; 25 Suppl 3():S1-5. PubMed ID: 8852537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lacidipine restores endothelium-dependent vasodilation in essential hypertensive patients.
    Taddei S; Virdis A; Ghiadoni L; Uleri S; Magagna A; Salvetti A
    Hypertension; 1997 Dec; 30(6):1606-12. PubMed ID: 9403590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium antagonists and endothelial function: focus on nitric oxide and endothelin.
    Godfraind T; Salomone S
    Cardiovasc Drugs Ther; 1996 Sep; 10(4):439-46. PubMed ID: 8924057
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benidipine improves endothelial function in renal resistance arteries of hypertensive rats.
    Dohi Y; Kojima M; Sato K
    Hypertension; 1996 Jul; 28(1):58-63. PubMed ID: 8675265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vivo binding of (+)-[3H]PN 200-110 to peripheral tissues and brain of spontaneously hypertensive rats: effect of lacidipine.
    Mennini T; Taddei C; Uslenghi A; Cagnotto A; Micheli D; Trist D; Gaviraghi G; Ratti E
    J Pharm Pharmacol; 1993 May; 45(5):430-3. PubMed ID: 8099961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of nitric oxide synthase inhibitor N(omega) nitro-L-arginine methyl ester on relaxant responses to calcium channel antagonists in isolated aortic rings from Dahl normotensive and hypertensive rats.
    Duggan JA; Tabrizchi R
    J Cardiovasc Pharmacol; 2002 Mar; 39(3):354-62. PubMed ID: 11862114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pranidipine enhances the action of nitric oxide released from endothelial cells.
    Yang J; Fukuo K; Morimoto S; Niinobu T; Suhara T; Ogihara T
    Hypertension; 2000 Jan; 35(1 Pt 1):82-5. PubMed ID: 10642279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
    Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nitric oxide synthase isotype expression in salt-sensitive and salt-resistant Dahl rats.
    Ni Z; Oveisi F; Vaziri ND
    Hypertension; 1999 Oct; 34(4 Pt 1):552-7. PubMed ID: 10523325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.